Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Medtronic
McKesson
Colorcon
Harvard Business School

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

PHOTREXA VISCOUS IN DEXTRAN 20% Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Photrexa Viscous In Dextran 20% patents expire, and what generic alternatives are available?

Photrexa Viscous In Dextran 20% is a drug marketed by Avedro Inc and is included in one NDA.

The generic ingredient in PHOTREXA VISCOUS IN DEXTRAN 20% is riboflavin 5'-phosphate sodium. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate sodium profile page.

Summary for PHOTREXA VISCOUS IN DEXTRAN 20%
Drug patent expirations by year for PHOTREXA VISCOUS IN DEXTRAN 20%

US Patents and Regulatory Information for PHOTREXA VISCOUS IN DEXTRAN 20%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avedro Inc PHOTREXA VISCOUS IN DEXTRAN 20% riboflavin 5'-phosphate sodium SOLUTION/DROPS;OPHTHALMIC 203324-002 Apr 15, 2016 RX Yes Yes   Start Trial   Start Trial   Start Trial
Avedro Inc PHOTREXA VISCOUS IN DEXTRAN 20% riboflavin 5'-phosphate sodium SOLUTION/DROPS;OPHTHALMIC 203324-002 Apr 15, 2016 RX Yes Yes   Start Trial   Start Trial   Start Trial
Avedro Inc PHOTREXA VISCOUS IN DEXTRAN 20% riboflavin 5'-phosphate sodium SOLUTION/DROPS;OPHTHALMIC 203324-002 Apr 15, 2016 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Johnson and Johnson
Harvard Business School
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.